DOCSLIB.ORG

Diagnostic Radiology Resident Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnostic Radiology Resident Manual DIAGNOSTIC RADIOLOGY RESIDENT MANUAL Revised August 5, 2020 SECTION 1 ______________________________________________________________________________________________________ 10 DEFINITION 11 GOALS 11 SPECIFIC OBJECTIVES 11 Medical expert/clinical decision-maker 11 Communicator 12 Collaborator 13 Manager 13 Health Advocate 14 Scholar 14 Professional 15 Training in Canada 16 Organizational Outline of the Program 16 Residency Training Committee 16 General Terms of Reference for Residency Training Committees 17 OVERVIEW OF ROUNDS AND TEACHING 20 Resident Responsibilities and Etiquette 21 JOURNAL CLUB (currently being discussed and revamped): 22 VISITING PROFESSOR PROGRAM: 22 ETHICS TRAINING: 22 COMMUNICATIONS TRAINING: 22 RESIDENT CALL DUTIES 22 ON CALL REPORTING POLICY 23 POST CALL POLICY 24 The Diagnostic Radiology Report 24 Written Communication 26 Direct Communication 26 SUPERVISION OF RESIDENTS 27 ATTENDING RADIOLOGIST RESPONSIBILITIES 27 RESIDENT RESPONSIBILITIES 28 Program Outline 29 By Number of Months Per Year 29 Program Outline By # Of Months Per Rotation 30 PGY1 ROTATIONS 31 RESIDENT EVALUATIONS: 32 Background: 32 Process of Evaluation: 32 What is WebEvaluation? 32 Core Benefits of WebEval 32 Benefits for Electronic Evaluation: 33 How does it work? 33 Guide To Resident Evaluation 34 EVALUATION TOOLS 34 Contingencies for Failure to Meet Defined Minimum Performance Standards 35 Evaluation Process 38 Conflict Resolution and Appeals 40 Appeal Procedure For An Unsatisfactory Evaluation 41 Pathway for Appeals 41 RESIDENT RESEARCH 42 DEPARTMENT OF DIAGNOSTIC IMAGING _____________________________________________________________ 42 REQUIREMENTS AND RESOURCES ____________________________________________________________________ 42 (AUGUST 2016) _______________________________________________________________________________________________ 42 REQUIREMENT BASED ON RCPSC LEARNING OBJECTIVES _____________________________________ 42 QUALIFYING PROJECT TYPES ___________________________________________________________________________ 42 LESS DESIRABLE PROJECT TYPES ____________________________________________________________________ 42 DEFINITION OF COMPLETION ____________________________________________________________________________ 42 AND EITHER OF THE TWO BELOW ______________________________________________________________________ 42 TIME ____________________________________________________________________________________________________________ 43 ANY RESIDENT THAT COMPLETES THEIR RESEARCH PROJECT WITHIN THE EARLY YEARS OF RESIDENCY_____________________________________________________________________________________ 43 RESIDENTS MAY ALSO APPLY TO DO RESEARCH ELECTIVES DURING THEIR PGY1 TRAINING ____________________________________________________________________________________________________________ 43 EVALUATION _________________________________________________________________________________________________ 43 RESEARCH MODULES _____________________________________________________________________________________ 43 MENTORS ____________________________________________________________________________________________________________ 43 PROJECT APPROVAL, ETHICS AND FINANCIAL IMPACT STATEMENT _________________________ 44 KEY RESEARCH CONTACTS WITHIN DEPARTMENT OF MEDICAL IMAGING __________________ 44 ROLE OF THE RESEARCH DIRECTOR __________________________________________________________________ 44 ROLE OF THE DISCIPLINE RESEARCH ASSISTANT _________________________________________________ 44 COMPOSITION OF THE DIRADS GROUP _______________________________________________________________ 45 AT PRESENT, THE GROUP MEMBERS ARE ____________________________________________________________ 45 DR. CONOR MAGUIRE, ASSOCIATE PROFESSOR, DISCIPLINE OF RADIOLOGY ([email protected]) ___________________________________________________________________________________________ 45 MICHELLE SIMMS, DISCIPLINE RESEARCH ASSISTANT ([email protected]) __________________ 45 ROLE OF THE DIRADS GROUP ___________________________________________________________________________ 45 SERVICES PROVIDED TO RESIDENTS __________________________________________________________________ 45 FINANCIAL SUPPORT FOR RADIOLOGY RESEARCH _______________________________________________ 46 PRESENTATION ______________________________________________________________________________________________ 47 EACH RESIDENT MUST PRESENT AT A CONFERENCE AT SOME POINT DURING THEIR RESIDENCY ___________________________________________________________________________________________________ 47 JOURNAL CLUB _____________________________________________________________________________________________ 47 APPENDIX 1 ___________________________________________________________________________________________________ 48 PGY1 ____________________________________________________________________________________________________________ 48 AT THE ONSET OF ANY RADIOLOGY RESEARCH PROJECT A SHORT DESCRIPTION OF THE PROJECT MUST BE ___________________________________________________________________________________ 48 PGY2 ____________________________________________________________________________________________________________ 48 PGY3 ____________________________________________________________________________________________________________ 49 PGY4 ____________________________________________________________________________________________________________ 49 APPENDIX 2 ___________________________________________________________________________________________________ 49 MEDICAL EXPERT _____________________________________________________________________________________________ 49 UNDERSTANDS TO ROLE OF RESEARCH IN MAINTAINING CLINICAL EXPERTISE ___________________ 49 COMMUNICATOR ____________________________________________________________________________________________________ 49 COLLABORATOR_________________________________________________________________________________________________ 49 MANAGER____________________________________________________________________________________________________ 50 INDEPENDENTLY IDENTIFY AN AREA OF RESEARCH INTEREST AND A RESEARCH MENTOR _____________________________________________________________________________________ 50 DEMONSTRATE EFFECTIVE TIME MANAGEMENT IN RESEARCH SETTING ________ 50 HEALTH ADVOCATE ______________________________________________________________________________________ 50 RECOGNIZE THE CONTRIBUTIONS OF SCIENTIFIC RESEARCH IN IMPROVING THE HEALTH OF PATIENTS AND COMMUNITIES ____________________________________________ 50 SCHOLAR ____________________________________________________________________________________________________ 50 APPENDIX 3 ___________________________________________________________________________________________________ 51 A THREE-PHASE VENTURE _______________________________________________________________________________ 51 2. STUDY _____________________________________________________________________________________________________ 51 3. PRESENTATION _________________________________________________________________________________________ 51 1) WHAT IS YOUR QUESTION? BE SPECIFIC. (THERE MAY BE MORE THAN ONE - BE VERY PRECISE IN DESCRIBING WHAT THEY ARE. THIS IS THE MOST IMPORTANT PART.) 52 2) WHAT DO YOU EXPECT TO FIND? WHAT OTHER POSSIBLE ANSWERS COULD THERE BE? _____________________________________________________________________________________________________________ 52 A) WHY IS IT IMPORTANT TO ANSWER THIS QUESTION? WHAT EFFECT WILL YOUR ANSWER HAVE? _____________________________________________________________________________________________ 52 B) HOW ARE YOU GOING TO ANSWER THIS QUESTION? _____________________________________ 52 C) WHAT STATISTICS WILL BE USED IN THE ANALYSIS OF THE DATA? __________________ 52 PILOT STUDIES ______________________________________________________________________________________________ 52 COMPLETION OF PROJECT _______________________________________________________________________________ 54 GUIDELINES FOR MANUSCRIPT _________________________________________________________________________ 54 ABSTRACT: CLEARLY STATE THE PURPOSE OF STUDY AND WHY IT IS IMPORTANT. __ 54 APPENDIX 4 ___________________________________________________________________________________________________ 55 HEALTH RESEARCH ETHICS BOARD (HREB)_________________________________________________________ 55 FINANCIAL IMPACT STATEMENT ________________________________________________________________________ 55 RESIDENT TRAVEL 56 OTHER RELEVANT DEPARTMENTAL POLICIES 58 CONFERENCE LEAVE 58 SICK LEAVE 58 VACATION TIME 58 Critical Incident and Stress Policy 59 PURPOSE 59 SCOPE 59 DEFINITIONS 59 POLICY AND PROCEDURES 60 Reporting a Critical Incident 60 Reporting a Significant Stressor 60 Referral and Meeting Guidelines 60 Harassment Policy 61 Memorial University Residency Program Safety Policy 61 Dress Code as per Memorial University Faculty of Medicine 62 PROGRAM TRANSFER POLICY 62 Eastern Health Policies 63 SECTION 2_____________________________________________________________________________________________________ 65 INTRODUCTION 66 SECTION 3_____________________________________________________________________________________________________ 67 PGY1 Radiology Ultrasound Rotation Objectives 68 PGY1 GI Radiology and Plain Film Rotation Objectives 70 PGY1 Radiology Anatomy and Research Rotation Objectives 72 PGY3 Angiography/Interventional Radiology 75 PGY2 Body CT GI/GU Imaging (HSC/SC) 79 PGY2 Body Imaging (HSC) 87 PGY3 Body Imaging
Load more

Recommended publications
  • Brain Imaging with MRI and CT: an Image Pattern Approach Edited by Zoran Rumboldt, Mauricio Castillo, Benjamin Huang and Andrea Rossi Index More Information
    Cambridge University Press 978-0-521-11944-3 - Brain Imaging with MRI and CT: An Image Pattern Approach Edited by Zoran Rumboldt, Mauricio Castillo, Benjamin Huang and Andrea Rossi Index More information INDEX abnormalities without significant mass effect 241 low-grade (diffuse) 334, 335, 337 cavernous sinus, invasion 85 abscesses 295, 317, 319, 321, 327, 329 pilocytic 129, 356, 357 cavernous sinus asymmetry, normal 101 cerebral abscess 322, 323 pleomorphic xanthoastrocytoma 340, 341 cavernous sinus hemangioma 97, 99, 105, 249, 297, operative site 169, 276, 277 SEGA 221, 305, 307, 309, 351, 353, 403 367, 376, 377 pyogenic abscess 325, 331 asymmetric CSF-containing spaces 299 cavernous sinus meningioma 249 vasogenic edema 65 atherosclerosis 253 cavernous sinus thrombosis, superior ophthalmic acquired intracranial herniations 196, 197 atretic parietal encephalocele 150, 151 vein (SOV) 103 ACTH-producing tumors 81 atypical parkinsonian disorders (APDs) 115 CD1aþ histiocytes 71, 89 acute disseminated encephalomyelitis (ADEM) 29, atypical teratoid–rhabdoid tumor (ATRT) 139 celiac disease 177 230, 231, 237, 257 AVM hemorrhage 73 central nervous system acute hypertensive encephalopathy (PRES) involvement in aggressive lymphoma 279 29, 64, 65 bacterial endocarditis 253 vasculitis 53, 237, 243, 251, 253 Addison disease 61 bacterial meningitis 277 central nervous system lymphoma adenoid cystic carcinoma 249 banana sign 125 primary 17, 29, 245 adrenoleukodystrophy 60, 61 Baraitser–Reardon syndrome 385 secondary 243, 245, 281, 289 protein (ALDP) 61
    [Show full text]
  • Abstracts of Scientific Papers
    49th Sao Paulo Radiological Meeting 1st Interventional Radiology Meeting May 2-5, Sao Paulo, Brazil Abstracts of Scientific Papers ORGANIZATION SUPPORT SUMMARY ABDOMINAL / DIGESTIVE TRACT ....................... 4 PHYSICS / QUALITY CONTROL .......................... 36 Original Paper ............................................................... 4 Original Paper ............................................................. 36 Posters (PI) ...................................................................... 4 Digital Presentation (PD) .............................................. 36 Digital Presentation (PD) ................................................ 4 Oral Presentation (TL) .................................................... 5 IT / MANAGEMENT ................................................ 37 Pictorial Essay ............................................................... 6 Original Paper ............................................................. 37 Posters (PI) ...................................................................... 6 Posters (PI) .................................................................... 37 Digital Presentation (PD) ................................................ 7 Digital Presentation (PD) .............................................. 37 Literature Review ....................................................... 12 Oral Presentation (TL) .................................................. 38 Posters (PI) .................................................................... 12 INTERVENTION ......................................................
    [Show full text]
  • Pituitary Incidentalomas in Paediatric Age Are Different from Those Described in Adulthood
    Pituitary (2019) 22:124–128 https://doi.org/10.1007/s11102-019-00940-4 Pituitary incidentalomas in paediatric age are different from those described in adulthood Pedro Souteiro1,2,3 · Rúben Maia4 · Rita Santos‑Silva2,5 · Rita Figueiredo4 · Carla Costa2,5 · Sandra Belo1 · Cíntia Castro‑Correia2,5 · Davide Carvalho1,2,3 · Manuel Fontoura2,5 Published online: 25 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose Guidelines on pituitary incidentalomas evaluation and management are limited to adults since there are no data on this matter in the paediatric population. We aim to analyse the morphologic characteristics, hormonal profile and follow-up of these lesions in children. Methods We have searched for pituitary incidentalomas in the neuroimaging reports and electronic medical records of the Paediatric Endocrinology Clinic of our centre. Patients with 18 years-old or less were included. Results Forty-one incidentalomas were identified, 25 of them (62.4%) in females. The mean age at diagnosis was 12.0 ± 4.96 years-old. Headaches were the main reason that led to image acquisition (51.2%) and MRI was the imaging method that detected the majority of the incidentalomas (70.7%). The most prevalent lesion was pituitary hypertrophy (29.3%), which was mainly diagnosed in female adolescents (91.7%), followed by arachnoid cysts (17.1%), pituitary adenomas (14.6%) and Rathke’s cleft cysts (12.2%). Most patients (90.2%) did not present clinical or laboratorial findings of hypopituitarism or hormonal hypersecretion. Four patients presented endocrine dysfunction: three had growth hormone deficiency and one had a central precocious puberty.
    [Show full text]
  • Findings of Brain Magnetic Resonance Imaging in Girls with Central Precocious Puberty Compared with Girls with Chronic Or Recurrent Headache
    Journal of Clinical Medicine Article Findings of Brain Magnetic Resonance Imaging in Girls with Central Precocious Puberty Compared with Girls with Chronic or Recurrent Headache Shin-Hee Kim 1, Moon Bae Ahn 2 , Won Kyoung Cho 2 , Kyoung Soon Cho 2, Min Ho Jung 3,* and Byung-Kyu Suh 2 1 Department of Pediatrics, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon 21431, Korea; [email protected] 2 Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; [email protected] (M.B.A.); [email protected] (W.K.C.); [email protected] (K.S.C.); [email protected] (B.K.S.) 3 Department of Pediatrics, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Korea * Correspondence: [email protected] Abstract: In the present study, the results of brain magnetic resonance imaging (MRI) in girls with central precocious puberty (CPP) were compared those in with girls evaluated for headaches. A total of 295 girls with CPP who underwent sellar MRI were enrolled. A total of 205 age-matched girls with chronic or recurrent headaches without neurological abnormality who had brain MRI were included as controls. The positive MRI findings were categorized as incidental non-hypothalamic–pituitary (H–P), incidental H–P, or pathological. Positive MRI findings were observed in 39 girls (13.2%) with Citation: Kim, S.-H.; Ahn, M.B.; Cho, CPP; 8 (2.7%) were classified as incidental non-H–P lesions, 30 (10.2%) as incidental H–P lesions, and 1 W.K.; Cho, K.S.; Jung, M.H.; Suh, B.-K.
    [Show full text]
  • Hamartoma of the Tuber Cinereum: a Comparison of MR and CT Findings in Four Cases
    497 Hamartoma of the Tuber Cinereum: A Comparison of MR and CT Findings in Four Cases 1 2 Edward M. Burton " Hamartoma of the tuber cinereum is a well-recognized cause of central precocious WilliamS. Ball, Jr.1 puberty. We report three patients with an isodense, nonenhancing mass within the Kerry Crone3 interpeduncular cistern identified by CT. In a fourth patient, the CT scan was normal. Lawrence M. Dolan4 MR imaging was obtained in all cases and demonstrated a sessile or pedunculated mass of the posterior hypothalamus arising from the region of the tuber cinereum. The smallest mass was 2 mm in diameter and was found in the patient in whom the CT scan was normal. The signal intensity of the masses was generally homogeneous and isointense relative to gray matter on T1- and intermediate-weighted images, and hyper­ intense on T2-weighted images. MR imaging accurately diagnoses hypothalamic hamartomas, identifies small hamar­ tomas of the tuber cinereum more sensitively than CT does, and provides optimal imaging for serial evaluation while the patient is being treated medically. Central (neurogenic or true) precocious puberty is caused by premature activation of the hypothalamic-pituitary axis, resulting in sexual maturation prior to age 7112 years in females and age 9 years in males . Hamartoma of the tuber cinereum is a well-recognized cause of central precocious puberty [1 , 2] , with approximately 90 cases previously reported in the radiologic literature [3-9]. There are, however, few reports describing its appearance on CT [6-12] and MR imaging [9, 13]. We report four cases of hypothalamic hamartoma causing precocious puberty, and describe their pertinent CT and MR characteristics.
    [Show full text]
  • Pituitary, Parasellar and Pineal Region Tumors Pineal Region Tumors I
    PITUITARY, PARASELLARR AND PITUITARY, PARASELLAR AND PINEAL REGION TUMORS PINEAL REGION TUMORS I. PITUITARY REGION TUMORS II. PARASELLAR REGION TUMORS Bert De Foer III. PINEAL REGION TUMORS MD, PhD, EDiNR, EDiHNR ESHNR vice – president GZA Hospitals, Antwerp, Belgium EUROPEAN COURSE IN NEURORADIOLOGY, DIAGNOSTIC and INTERVENTIONAL 15th CYCLE 2nd MODULE ON TUMORS APRIL 29th –MAY 3th 2019, FLANDERS MEETING & CONVENTION CENTRE ANTWERP, BELGIUM PITUITARY, PARASELLARR AND PITUITARY, PARASELLARR AND PINEAL REGION TUMORS PINEAL REGION TUMORS I. PITUITARY REGION TUMORS I. PITUITARY REGION TUMORS II. PARASELLAR REGION TUMORS I. IMAGING PROTOCOL II. NORMAL ANATOMY / VARIANTS III. PINEAL REGION TUMORS III. PITUITARY TUMORS / LESIONS IV. DIFFERENTIAL DIAGNOSIS II. PARASELLAR REGION TUMORS III. PINEAL REGION TUMORS PITUITARY, PARASELLARR AND PITUITARY, PARASELLARR AND PINEAL REGION TUMORS PINEAL REGION TUMORS I. PITUITARY REGION TUMORS IMAGING PROTOCOL : PITUITARY GLAND – SELLAR REGION I. IMAGING PROTOCOL • COR TSE T2-WEIGHTED SEQUENCE II. NORMAL ANATOMY / VARIANTS • COR SE T1-WEIGHTED SEQUENCE • (MRA: 3D TOF MRA) III. PITUITARY TUMORS / LESIONS • COR TSE T1-WEIGHTED – DYNAMIC DURING GD INJECTION IV. DIFFERENTIAL DIAGNOSIS • COR SE T1-WEIGHTED SEQUENCE II. PARASELLAR REGION TUMORS • SAG SE T1-WEIGHTED SEQUENCE III. PINEAL REGION TUMORS • HALF DOSE OF Gd ! • DIFFUSION-WEIGHTED IMAGING PITUITARY, PARASELLARR AND PITUITARY, PARASELLARR AND PINEAL REGION TUMORS PINEAL REGION TUMORS I. PITUITARY REGION TUMORS I. IMAGING PROTOCOL II. NORMAL ANATOMY / VARIANTS III. PITUITARY TUMORS / LESIONS COR TSE T2 SAG SE T1 + Gd IV. DIFFERENTIAL DIAGNOSIS II. PARASELLAR REGION TUMORS III. PINEAL REGION TUMORS COR SE T1 COR SE T1 + Gd COR dyn TSE T1 + Gd PITUITARY, PARASELLARR AND PITUITARY, PARASELLARR AND PINEAL REGION TUMORS PINEAL REGION TUMORS I.
    [Show full text]
  • Onc26. Pituitary Tumors, Apoplexy, Empty Sella.Pdf
    PITUITARY TUMORS Onc26 (1) Pituitary Tumors Last updated: December 22, 2020 Differential Diagnosis of Sellar and Parasellar Tumors ................................................................... 1 PITUITARY ADENOMAS ................................................................................................................... 1 PATHOPHYSIOLOGY, PATHOLOGY, ETIOLOGY ....................................................................................... 2 CLASSIFICATION .................................................................................................................................... 2 Size ........................................................................................................................................ 2 Hormonal secretion ............................................................................................................... 2 Histology ............................................................................................................................... 2 EPIDEMIOLOGY ...................................................................................................................................... 4 CLINICAL FEATURES .............................................................................................................................. 4 1. Hormonal function control ................................................................................................ 4 2. Mass effect .......................................................................................................................
    [Show full text]
  • Update on Pituitary and Orbital Imaging
    Update on Sellar & Orbital Imaging Gabriella Szatmáry, MD, PhD Director of Neuro-Ophthalmology Neuroimager Hattiesburg Clinic, PA American Society of Neuroimaging 36th Annual Meeting 01/19/2013 2 Intra +/-Suprasellar 1. Adenoma 2. Abscess 3. Craniopharyngioma 4. Eosinophilic granuloma 5. Hyperplasia 6. Langerhans cell histio 7. Lymphocytic hypophysitis 8. Mets 9. RCC (pars intermedia ) 10. Granular cell tumor or choristoma (post pit) 01/19/2013 3 Ectopic Neurohypophysis A B Pre- (A) and post-Gd (B) sagittal T1 images show “bright spot” in tuber cinereum of the hypothalamus. Post pit. hyperintesity may be lost in DI. 4 9/2008 4/2008 2/2008 Pituitary apoplexy 86 y/o VA↓, anorexia Sellar lesions: Adenoma (15% of all IC tumors) enlarge bony sella (macro>10mm) 77 y/o ♂ diplopia ↑PRL 28 x XRT Rx Dostinex, Steroids L-thyroxin “Stalk effect” “Hook effect” Pituitary abscess 28-year-old man with febrile cephalalgia 7 Lymphocytic Hypophysitis Idiopathic inflammation of the pituitary gland Thickened, non tapering stalk (>2mm) Intense and homogeneous enhancement F:M = 8:1 8 Infundibular lesions 9 13 y/o ♀ VA ↓ SITA Standard 24-2 O.S. O.D. Rathke’s Cleft Cyst (RCC) RCC: intracystic nodule (mucin clump) with T1↑& T2↓ Derived from remnants of Rathke’s pouch. Byun et al. AJNR Am J Neuroradiol 21:485–488, March 2000 11 LANGERHANS CELL HISTIOCYTOSIS X 24 y/o ♂ with DI Bx of scalp and groin lesion T12 & pit mets Proliferative do. of Langerhan’s cells Granular cell tumour Sag T1WI C+ shows a well defined enhancing mass within the pituitary stalk.
    [Show full text]
  • Hypothalamic Hamartomas. Part 1. Clinical, Neuroimaging, and Neurophysiological Characteristics
    See the companion article in this issue (E7). Neurosurg Focus 34 (6):E6, 2013 ©AANS, 2013 Hypothalamic hamartomas. Part 1. Clinical, neuroimaging, and neurophysiological characteristics SANDEEP MITTAL, M.D., F.R.C.S.C.,1 MONIKA MITTAL, M.D.,1 JOSÉ LUIS MONTES, M.D.,2 JEAN-PIErrE FArmER, M.D., F.R.C.S.C.,2 AND FREDERICK ANDErmANN, M.D., F.R.C.P.C.3 1Department of Neurosurgery, Comprehensive Epilepsy Center, Wayne State University, Detroit Medical Center, Detroit, Michigan; 2Department of Neurosurgery, Montreal Children’s Hospital; and 3Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada Hypothalamic hamartomas are uncommon but well-recognized developmental malformations that are classi- cally associated with gelastic seizures and other refractory seizure types. The clinical course is often progressive and, in addition to the catastrophic epileptic syndrome, patients commonly exhibit debilitating cognitive, behavioral, and psychiatric disturbances. Over the past decade, investigators have gained considerable knowledge into the pathobio- logical and neurophysiological properties of these rare lesions. In this review, the authors examine the causes and molecular biology of hypothalamic hamartomas as well as the principal clinical features, neuroimaging findings, and electrophysiological characteristics. The diverse surgical modalities and strategies used to manage these difficult le- sions are outlined in the second article of this 2-part review. (http://thejns.org/doi/abs/10.3171/2013.3.FOCUS1355)
    [Show full text]
  • 26Th Annual National Conference of the Indian Academy of Neurology
    CONFERENCE PROCEEDINGS IANCON 2018: 26th Annual National Conference of the Indian Academy of Neurology SEPTEMBER 27-30 | PANDIT DEENDAYAL UPADHYAY AUDITORIUM, SCIENCE COLLEGE CAMPUS, RAIPUR BILATERAL GREATER OCCIPITAL NERVE BLOCK IN neurogenesis, angiogenesis, immune modulation, neural TREATMENT OF CHRONIC MIGRAINE: EXPERIENCE plasticity, secretion of growth factors, etc. Translation of FROM A MULTISPECIALTY HOSPITAL IN NORTH INDIA these advances into meaningful therapeutic options is required. A meta-analysis was conducted with the aim Dr Ruby Chopra, Bathinda; to assess the effectiveness and safety of cell therapies, Prof Debashish Chowdhury, New Delhi studied as monotherapy in adult patients with stroke Greater occipital nerve (GON) block is the most widely and published in English language. Trials investigating used peripheral nerve block for different primary the use of stem cell therapy in adult patients who had headache disorders. It is cheap, minimally invasive, has experienced a stroke and in any phase from acute to no side effects, is associated with a reasonable duration chronic phase, were included. of pain relief and reduces pill burden and toxicity of Trials investigating combination therapies including abortive and prophylactic medication. There is no stem cells with other therapies were excluded. This Indian data on the use of GON block for treatment of review and meta-analysis provides evidence for the primary headaches. safety, feasibility and preliminary efficacy of cell A study was therefore conducted with patients therapies for stroke. There is substantial heterogeneity attending Neurology OPD from December 2016 to due to differences in stroke type, route of intervention, April 2018 who were diagnosed with chronic migraine timing of intervention, cell types, dose, etc.
    [Show full text]
  • Oral Presentations S2 • Turkish Society of Magnetic Resonance 23Rd Annual Meeting Eurasian J Med 2018; 50: (Suppl 1): S1-S137
    Oral Presentations S2 • Turkish Society of Magnetic Resonance 23rd Annual Meeting Eurasian J Med 2018; 50: (Suppl 1): S1-S137 DOI 10.5152/eurasianjmed.2018.02052018 O - 01 Materials and Methods: Between January 2017 and January 2018, 89 patients without abdominal MR imaging findings who underwent abdomi- ASSESSMENT OF PANCREATIC nal 3 T diffusion weighted imaging, (b=0, b=600 s/mm2) were retrospec- ULTRASONOGRAPHY AND MRI tively included. ADC mean values of the spleen were measured at MR Workstation. Measurements were performed with 25 mm2 ROIs at the FINDINGS IN RELATION TO GLUCOSE splenic hilus level. The average of four ADC mean measurements was TOLERANCE TEST IN PATIENTS WITH calculated to reduce random variability in the measurements. Pearsons correlation coefficient test was used to evaluate the relationship between BETA THALASSEMIA MAJOR age and ADC mean values. YASEMIN ALTINTAS Results: Twenty-four of the patients included in the study were males and 65 Private Adana Middle East Hospital, Adana, Turkey were females. The mean age was 45.9 years (range, 19-76 years). The mean ADC value was 0.9+0.13x10-3 mm2/s (range, 0.66-1.2x10-3 mm2/sn). There was Abstract a negative correlation between age and ADC mean values (r=-0.526, p=0.001). Objective: The most important cause of mortality is heart failure due Conclusion: There was a negative correlation between age and ADC mean to iron accumulation in beta thalassemia major and MRI have come into values. It may be necessary to consider age when assessing spleen s ADC values. routine use in evaluation of the iron load.
    [Show full text]
  • Imaging Spectrum of Sellar and Parasellar Masses in a Paediatric
    Hong Kong J Radiol. 2021;24:129-40 | https://doi.org/10.12809/hkjr2117210 PICTORIAL ESSAY Imaging Spectrum of Sellar and Parasellar Masses in a Paediatric Population: a Pictorial Essay S Gupta, S Singh, R Dixit, A Prakash Department of Radiology, Maulana Azad Medical College, India INTRODUCTION Paediatric sellar/suprasellar mass Tumours in the sellar and suprasellar regions are not uncommon in the paediatric population and differ to adult sellar tumours with respect to type and frequency. Identify the location of the mass Such masses comprise about 10% of all paediatric - Sellar brain tumours.1 Magnetic resonance imaging (MRI) - Sellar-suprasellar - Suprasellar renders high intrinsic soft tissue contrast and greater - Lesions of the pituitary stalk anatomic detail. It remains the mainstay in diagnosis and - Miscellaneous characterisation of these lesions. Computed tomography may provide complimentary information, especially in identifying the presence of calcifications. The first step Characterise the mass based on imaging morphology in diagnosing these lesions is to determine their anatomic - Solid location, followed by an assessment of their intrinsic - Solid-cystic - Cystic signal and enhancement pattern. Cystic component / calcification also needs to be looked at as it aids characterisation of the lesions (Figure 1). The clinical Look for key imaging features symptoms and hormonal profile along with the age of - Intrinsic magnetic resonance signal patterns the child are also important to narrow down the list of - Contrast enhancement patterns differential diagnoses. Clinical symptoms can be non- - ± Calcifications specific due to raised intracranial pressure or specifically - ± Cysts - Other findings on brain imaging related to hormonal derangement. Altered vision may occur secondary to mass effect on the optic apparatus.1,2 NORMAL ANATOMY Differential diagnoses The sellar, suprasellar, and parasellar regions are an Figure 1.
    [Show full text]